CDNA
CareDx, Inc.
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$85.86
−2.95%Forward multiples
Based on analyst estimates
- P/E forward
- 58.14x
- P/E 2026E
- 48.22x
- P/E 2027E
- 54.43x
- P/E 2028E
- 39.59x
- P/S forward
- 8.12x
Trailing multiples
Trailing twelve months
- P/E TTM
- 34.48x
- PEG TTM
- —
- Price / book
- 9.65x
- Price / sales
- 9.07x
- Price / cash flow
- 65.36x
Enterprise value
- Enterprise value
- $4.3B
- EV / sales
- 8.62x
- EV / EBITDA
- 150.33x
- EV / EBIT
- 1039.46x
- Market cap
- $4.5B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Sep 1, 2026